2-pyrazolyl-N6-substituted adenosine derivatives as high affinity and selective adenosine A3 receptor agonists

被引:30
作者
Elzein, E
Palle, V
Wu, YZ
Maa, TN
Zeng, DW
Zablocki, J
机构
[1] CV Therapeut Inc, Dept Bioorgan Chem, Palo Alto, CA 94304 USA
[2] CV Therapeut Inc, Dept Drug Res & Pharmacol Sci, Palo Alto, CA 94304 USA
关键词
D O I
10.1021/jm049682h
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
We describe the synthesis of new high affinity and selective A(3)-adenosine receptor (A(3)-AdoR) agonists. Introduction of a methyl group at the N-6-position of the A(2A)-AdoR selective 2-pyrazolyladenosine analogues (Figure 2) brought about a substantial increase in the A(3)-AdoR binding affinity and selectivity. While the N-6-desmethyl analogues 3a and 4 were inactive at the A(3)AdoR (K-i > 10,muM), the corresponding N-6-methyl analogues 5 and 22 showed good binding affinity at the A(3)-AdoR (K-i = 73 and 97 nM, respectively). Replacement of the carboxamide group in 5 with different heteroaryl groups resulted in analogues with high affinities and selectivity for the A(3)-AdoR. (2R,3S,4R)-tetrahydro-2-(hydroxymethyl)-5-(6-(methylamino)-2-(4-(pyridin-2-yl)-1H-pyrazol-1-yl)-9H-purin-9-yl)furan-3,4-diol (15, Ki = 2 nM) displayed high selectivity for the A(3)-AdoR versus A(1)- and A(2A)-AdoRs (selectivity ratios of 1900 and >2000, respectively).
引用
收藏
页码:4766 / 4773
页数:8
相关论文
共 22 条
  • [1] ABRIU T, 1991, EUR J PHARMACOL, V196, P69
  • [2] NEW COPPER CHEMISTRY .3. NEW PREPARATIONS OF ETHYL 3,3-DIETHOXYPROPIONATE AND (ETHOXYCARBONYL)MALONDIALDEHYDE - CU(I)-CATALYZED ACETAL FORMATION FROM A CONJUGATED TRIPLE BOND
    BERTZ, SH
    DABBAGH, G
    COTTE, P
    [J]. JOURNAL OF ORGANIC CHEMISTRY, 1982, 47 (11) : 2216 - 2217
  • [3] EFFECTS OF SELECTIVE A(1) AND A(2) ADENOSINE RECEPTOR AGONISTS ON CARDIOVASCULAR TISSUES
    CONTI, A
    MONOPOLI, A
    GAMBA, M
    BOREA, PA
    ONGINI, E
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1993, 348 (01) : 108 - 112
  • [4] DIONISOTTI S, 1992, N-S ARCH PHARMACOL, V346, P673
  • [5] Evidence for involvement of Wnt signaling pathway in IB-MECA mediated suppression of melanoma cells
    Fishman, P
    Madi, L
    Bar-Yehuda, S
    Barer, F
    Del Valle, L
    Khalili, K
    [J]. ONCOGENE, 2002, 21 (25) : 4060 - 4064
  • [6] Fredholm BB, 2001, PHARMACOL REV, V53, P527
  • [7] Gao ZH, 2001, J PHARMACOL EXP THER, V298, P209
  • [8] A new entry to 2-substituted purine nucleosides based on lithiation-mediated stannyl transfer of 6-chloropurine nucleosides
    Kato, K
    Hayakawa, H
    Tanaka, H
    Kumamoto, H
    Shindoh, S
    Shuto, S
    Miyasaka, T
    [J]. JOURNAL OF ORGANIC CHEMISTRY, 1997, 62 (20) : 6833 - 6841
  • [9] 2-SUBSTITUTION OF N-6-BENZYLADENOSINE-5'-URONAMIDES ENHANCES SELECTIVITY FOR A-3 ADENOSINE RECEPTORS
    KIM, HO
    JI, XD
    SIDDIQI, SM
    OLAH, ME
    STILES, GL
    JACOBSON, KA
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (21) : 3614 - 3621
  • [10] Klotz KN, 1998, N-S ARCH PHARMACOL, V357, P1